DDIT4 overexpression associates with poor prognosis in lung adenocarcinomaLi Song, Liyan Miao, Xiaoyun Lu et al.|Journal of Cancer|2021Cited by 33
Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC–MS/MS for therapeutic drug monitoringMenghua Zhang, Liyan Miao, Shenhao Jiang et al.|Journal of Pharmaceutical and Biomedical Analysis|2021Cited by 18
Study of genetic polymorphisms and steady-state trough concentrations of imatinib and its active metabolite in predicting efficacy in gastrointestinal stromal tumorsMenghua Zhang, Liyan Miao, Zhiyao Chen et al.|Frontiers in Pharmacology|2025Cited by 1
Method Development and Validation for Simultaneous Determination of Six Tyrosine Kinase Inhibitors and Two Active Metabolites in Human Plasma Using UPLC–MS/MS for Therapeutic Drug MonitoringMenghua Zhang, Liyan Miao, Lin Wang et al.|SSRN Electronic Journal|2021Cited by 0
Impact of administration route and gene polymorphisms on the serum concentration of voriconazole among Chinese patients with hematologic malignancies.Zhiyao Chen, Liyan Miao, Menghua Zhang et al.|PubMed|2025Cited by 0